KIT and neoplasm: GISTs are usually characterized by gain-of-function mutations in either the KIT or PDGFRA genes, leading to constitutive, ligand-independent activation of the respective receptor tyrosine kinases and downstream signaling pathways, resulting in uncontrolled tumor cell proliferation.